Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS EQUITY (DEFICIT) (UNAUDTIED)

v3.24.1.1.u2
CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS EQUITY (DEFICIT) (UNAUDTIED) - USD ($)
Total
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Balance, shares at Dec. 31, 2022   93,087,796    
Balance, amount at Dec. 31, 2022 $ (7,416,859) $ 93,088 $ 61,188,442 $ (68,698,389)
Issuance of stock options 30,029 $ 0 30,029 0
Stock issued for cash exercise of options, shares   850,000    
Stock issued for cash exercise of options, amount 209,500 $ 850 208,650 0
Stock issued for cashless exercise of options, shares   311,880    
Stock issued for cashless exercise of options, amount 0 $ 312 (312) 0
Issuance of stock for compensation 120,000 0 120,000 0
Net loss (1,446,984) $ 0 0 (1,446,984)
Share based payments 120,000      
Balance, shares at Mar. 31, 2023   94,249,676    
Balance, amount at Mar. 31, 2023 (8,504,314) $ 94,250 61,546,809 (70,145,373)
Balance, shares at Dec. 31, 2023   94,360,107    
Balance, amount at Dec. 31, 2023 (782,897) $ 94,360 61,917,119 (62,794,376)
Stock issued for cash exercise of options, shares   9,285    
Stock issued for cash exercise of options, amount 0 $ 9 (9) 0
Net loss (2,558,991) 0 0 (2,558,991)
Gain on modification of related party debt 10,827,195 0 10,827,195 0
Share based payments 770,216 $ 0 770,216 0
Balance, shares at Mar. 31, 2024   94,369,392    
Balance, amount at Mar. 31, 2024 $ 8,255,523 $ 94,369 $ 73,514,521 $ (65,353,367)